S&Co INC Increased Bristol (BMY) Stake

June 20, 2017 - By Marie Mckinney

Investors sentiment decreased to 0.97 in Q4 2016. Its down 0.16, from 1.13 in 2016Q3. It dropped, as 86 investors sold BMY shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. 1.14 billion shares or 1.92% more from 1.12 billion shares in 2016Q3 were reported. Moreover, Piedmont Inv Advsr Ltd Liability Co has 0% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 397,996 shares. Nordea Investment Management Ab holds 0.04% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 243,178 shares. Mcgowan Grp Asset Mngmt reported 3,622 shares stake. Boulegeris Invests owns 36,720 shares for 1.3% of their portfolio. Nikko Asset Mgmt Americas accumulated 0.05% or 9,600 shares. Tiedemann Wealth Mngmt reported 0.13% stake. Boston Private Wealth Limited Liability Corporation invested in 228,175 shares. Shell Asset Mngmt has invested 0.36% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Yhb Inv Advsrs reported 0.72% stake. Country Tru Savings Bank has 100 shares. D E Shaw & owns 4.43M shares for 0.44% of their portfolio. Banced Corp has invested 1.17% in Bristol-Myers Squibb Co (NYSE:BMY). Fiduciary Trust Communication holds 0.19% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 98,230 shares. Mcmillion reported 64,660 shares. Strategy Asset Managers Lc invested in 1.4% or 131,824 shares.

Since February 27, 2017, it had 1 insider buy, and 6 insider sales for $9.91 million activity. $1.91M worth of Bristol-Myers Squibb Co (NYSE:BMY) was sold by ANDREOTTI LAMBERTO. Another trade for 12,000 shares valued at $681,240 was made by Samuels Theodore R. II on Monday, February 27. On Tuesday, March 14 the insider Schmukler Louis S sold $851,220. Another trade for 8,096 shares valued at $463,779 was made by Caldarella Joseph C on Wednesday, March 15. LEUNG SANDRA had sold 92,405 shares worth $5.27M on Friday, March 3.

S&Co Inc increased its stake in Bristol (BMY) by 894.6% based on its latest 2016Q4 regulatory filing with the SEC. S&Co Inc bought 327,110 shares as the company’s stock declined 1.04% while stock markets rallied. The institutional investor held 363,675 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $21.25M, up from 36,565 at the end of the previous reported quarter. S&Co Inc who had been investing in Bristol for a number of months, seems to be bullish on the $92.24B market cap company. It closed at $55.22 lastly. It is down 23.19% since June 20, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

S&Co Inc, which manages about $1.33B and $556.89M US Long portfolio, decreased its stake in Charter Communications Inc. by 17,966 shares to 947 shares, valued at $273,000 in 2016Q4, according to the filing. It also reduced its holding in Liberty Interactive Corp Q (NASDAQ:QVCA) by 234,235 shares in the quarter, leaving it with 382,765 shares, and cut its stake in Cl C.

More notable recent Bristol-Myers Squibb Co (NYSE:BMY) news were published by: Bloomberg.com which released: “Companies Get New Suit Limits as Supreme Court Backs Bristol-Myers” on June 19, 2017, also Thestreet.com with their article: “Bristol-Myers Squibb Is Poised for a Breakout” published on June 19, 2017, Businesswire.com published: “Bristol-Myers Squibb to Announce Results for Second Quarter 2017 on July 27” on June 12, 2017. More interesting news about Bristol-Myers Squibb Co (NYSE:BMY) were released by: Marketwatch.com and their article: “Bristol-Myers Squibb reports data from phase 1/2 trial for cancers associated …” published on June 02, 2017 as well as Fool.com‘s news article titled: “Is the Market Wrong About Bristol-Myers Squibb?” with publication date: June 15, 2017.

Bristol-Myers Squibb Co (NYSE:BMY) Ratings Coverage

Among 17 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 7 Hold. Therefore 41% are positive. Bristol-Myers Squibb Company had 37 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Friday, April 29 by UBS. As per Tuesday, June 14, the company rating was maintained by Jefferies. As per Monday, August 24, the company rating was upgraded by Piper Jaffray. The rating was maintained by Barclays Capital on Friday, April 29 with “Equal Weight”. The firm has “Sell” rating by Societe Generale given on Wednesday, April 6. The stock has “Buy” rating by Berenberg on Friday, January 22. Berenberg downgraded it to “Hold” rating and $70 target in Thursday, August 11 report. The firm has “Underweight” rating by Atlantic Securities given on Friday, December 18. As per Monday, December 19, the company rating was upgraded by Jefferies. Hilliard Lyons initiated the stock with “Neutral” rating in Monday, May 23 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.